INTRODUCTION
Alzheimer's disease (AD) is an age-related and progressive neurological disorder characterized by neuropathologic hallmarks such as neurofibrillary tangles and excessive deposition of a 40-to 42-aminoacid peptide, called the b-amyloid protein (Ab), in the human cortical parenchyma and cerebral vessel walls. The Ab is derived by proteolitic cleavage of the larger b-amyloid precursor protein (APP) (Kang et al., 1987; Ponte et al., 1988) . It includes the 28 residues located just outside the membrane and the first 11-15 residues of the transmembrane domain. The cloning of the APP cDNA revealed that at least three major forms of precursor (APP-695, APP-751, and APP-770) are generated by alternative splicings of a gene containing 18 exons located on the human chromosome 21 (Yoshikai et al., 1990) . All the APPs share a long extracellular amino-terminus segment, a transmembrane domain, and a short intracellular carboxyl-terminus. APP-751 and APP-770, which are mostly located in peripheral tissue (Dresse et al., 1994, for review) , contain an extracellular domain that shows homologies to the Kunitz inhibitor (Ponte et al., 1988; Tanzi et al., 1988; Kitaguchi et al., 1988) . APP-695 is the predominant form in the brain and is principally expressed by neurons (Golde et al., 1992; Sandbrink et al., 1994) .
